In vitro and in vivo assessment of the mutagenic activity of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-α-aspartyl]-l-phenylalanine 1-methyl ester, monohydrate (advantame)

Food and Chemical Toxicology

Volumn 49, Issue SUPPL. 1, 2011, Pages

  Otabe, A ^a   Fujieda, T ^a   Masuyama, T ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

Advantame; Genotoxicity; N N 3 (3 hydroxy 4 methoxyphenyl) propyl aspartyl l phenylalanine 1 methyl ester, monohydrate

Indexed keywords

ADVANTAME; SWEETENING AGENT; UNCLASSIFIED DRUG;

AMES TEST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL MUTATION; CELL SURVIVAL; CONTROLLED STUDY; ERYTHROCYTE; ESCHERICHIA COLI; GENE LOCUS; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MAMMAL CELL; MICRONUCLEUS TEST; MOUSE; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN; PHENOTYPE; RAT; SAFETY; SALMONELLA TYPHIMURIUM; TOXICITY TESTING;

ANIMALS; CARCINOGENICITY TESTS; CELL LINE, TUMOR; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; MICE; MICRONUCLEUS TESTS; SALMONELLA TYPHIMURIUM; SWEETENING AGENTS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MAMMALIA; SALMONELLA TYPHIMURIUM;

EID: 80755180839     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.06.045     Document Type: Article

References (23)

1. Agresti A., Mehta C.R., Patel N.R. Exact inference for contingency tables with ordered categories. J. Am. Stat. Assoc. 1990, 85:453-458.
2. Amacher D.E., Turner G.N. The detection of carcinogens from several chemical classes as mutagens in a modified L5178Y TK mutation assay. Environ. Mutagen. 1980, 2:254-255.
3. Amacher D.E., Paillet S.C., Ray V.A. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. 1. Application to genetic toxicology testing. Mutat. Res. 1979, 64:391-406.
4. Amacher D.E., Paillet S.C., Turner G.N., Ray V.A., Salsburg D.S. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. 2. Test validation and interpretation. Mutat. Res. 1980, 72:447-474.
5. Ames B.N., McCann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutat. Res. 1975, 31:347-364.
6. Amino Y., Mori K., Tomiyama Y., Sakata H., Fujieda T. Development of a new, low calorie sweetener: new aspartame derivative. Sweetness and Sweeteners: Biology, Chemistry and Psychophysics (ACS Symposium Series 979) 2008, 463-480. American Chemical Society (ACS), Washington, DC. K.W. Deepthi, G. DuBois (Eds.).
7. Clive D., Spector J.-A.F.S. Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells. Mutat. Res. 1975, 31:17-29.
8. Clive D., Johnson K.O., Spector J.-A.F.S., Batson A.G., Brown M.M.M. Validation and characterization of the L5178Y/TK mouse lymphoma mutagen assay system. Mutat. Res. 1979, 59:61-108.
9. Cole J., Arlett C.F., Green M.H.L. The fluctuation test as a more sensitive system for determining induced mutation in L5178Y mouse lymphoma cells. Mutat. Res. 1976, 41:377-386.
10. Cole J., Arlett C.F., Green M.H.L., Lowe J., Muriel W. A comparison of the agar cloning and microtitration techniques for assaying cell survival and mutation frequency in L5178Y mouse lymphoma cells. Mutat. Res. 1983, 111:371-386.
11. EEC, 2000. Commission Directive 2000/32/EC of 19 May 2000 adapting to technical progress for the 26th time Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. [Annex 4E - B.17. Mutagenicity - In vitro mammalian cell gene mutation test]. (European Economic Community). Off. J. Eur. Communities L136, 65-72.
12. EU Commission Directive 2009/163/EU of 22 December 2009 amending Directive 94/35/EC of the European Parliament and of the Council on sweeteners for use in foodstuffs with regard to neotame (European Commission). Off. J. Eur. Union 2009, L344:37-40.
13. Gibbons J.D. Nonparametric Statistical Inference 1985, Marcel Dekker, New York. second ed.
14. + reversion in Escherichia coli. Handbook of Mutagenicity Test Procedures 1984, 161. Elsevier Science Publishers BV, Amsterdam. second ed. B.J. Kilbey, M. Legator, W. Nicholas, C. Ramel (Eds.).
15. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113:173-215.
16. Morrison V., Ashby J. High resolution rodent bone marrow micronucleus assays of 1,2-dimethylhydrazine: implication of systemic toxicity and individual responders. Mutagenesis 1995, 10:129-135.
17. OECD, 1997. Guidelines for Testing of Chemicals, Section 4 -Health Effects, Guideline No. 476, Genetic toxicology: In vitro mammalian cell gene mutation tests. Organization for Economic Co-Operation and Development (OECD), July 21, 1997.
18. Robinson W.D., Green M.H.L., Cole J., Healy M.J.R., Garner R.C., Gatehouse D. Statistical evaluation of bacterial/mammalian fluctuation tests. UKEMS Sub-committee on Guidelines for Mutagenicity Testing Report. Part III. Statistical Evaluation of Mutagenicity Test Data 1989, 102. Cambridge University Press, Cambridge. D.J. Kirkland (Ed.).
19. Schmid W. The micronucleus test for cytogenetic analysis. Chemical Mutagens, Principles and Methods for their Detection 1976, vol. 4:31. Plenum Press, New York.
20. U.S. EPA, 1998. Health Effects Test Guidelines. OPPTS 870.5300 In vitro mammalian cell gene mutation test. U.S. Environmental Protection Agency, EPA 712-C-98-221.
21. U.S. FDA, 2000a. IV.C.1.a. Bacterial Reverse Mutation Test, in: Redbook 2000: Toxicological Principles for the Safety of Food Ingredients. U.S. Food and Drug Administration.
22. U.S. FDA, 2000b. IV.C.1.d. Mammalian erythrocyte micronucleus test, in: Redbook 2000: Toxicological Principles for the Safety of Food Ingredients. U.S. Food and Drug Administration.
23. U.S. FDA, 2008. Part 172-Food additives permitted for direct addition to food for human consumption. §172.829-Neotame, in: U.S. Code of Federal Regulations (CFR). Title 21: Food and Drugs (U.S. Food and Drug Administration). Government Printing Office (GPO), Washington (DC), pp. 86-87. Available from: <>. http://www.access.gpo.gov/nara/cfr/waisidx_08/21cfr172_08.html.